Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?
Abstract Background Diagnosis of C. difficile infection (CDI) is controversial because of the many laboratory methods available and their lack of ability to distinguish between carriage, mild or severe disease. Here we describe whether a low C. difficile toxin B nucleic acid amplification test (NAAT...
Main Authors: | Mark I. Garvey, Craig W. Bradley, Martyn A. C. Wilkinson, Elisabeth Holden |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13756-017-0283-z |
Similar Items
-
Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria
by: E. Casari, et al.
Published: (2018-03-01) -
Factors affecting development of Clostridium difficile infection in hospitalized pediatric patients in the country Georgia
by: Iuri Migriauli, et al.
Published: (2018-06-01) -
Binary Toxin and Death after Clostridium difficile Infection
by: Sabrina Bacci, et al.
Published: (2011-06-01) -
Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
by: Stefano Di Bella, et al.
Published: (2016-05-01) -
Mortality and <it>Clostridium difficile</it> infection: a review
by: Mitchell Brett G, et al.
Published: (2012-05-01)